Home › Chronic Lymphocytic Leukemia › Washington › Seattle
Pag-aaral pangklinika para sa Chronic Lymphocytic Leukemia sa Seattle, WA
Isang pag-aaral para sa Chronic Lymphocytic Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Seattle. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Nagre-recruitPhase 3
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-First Hill, Seattle
- FHCC at Northwest Hospital, Seattle
- at 1 pa
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- at 1 pa
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Nagre-recruitPhase 3
- Swedish Medical Center-First Hill, Seattle
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Nagre-recruitPhase 2
- Fred Hutchinson Cancer Center, Seattle
Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma
Nagre-recruitPhase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Nagre-recruitPhase 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Nagre-recruitPhase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
Nagre-recruitPhase 1/2
- Fred Hutchinson Cancer Research Center, Seattle
Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial
Nagre-recruitPhase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Nagre-recruitPhase 3
- Swedish Medical Center Swedish Cancer Institute First Hill Campus, Seattle
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Nagre-recruitPhase 1
- Fred Hutch Cancer Center, Seattle
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Nagre-recruitPhase 3
- Fred Hutchinson Cancer Research Center, Seattle
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Nagre-recruitPhase 3
- Swedish Medical Center-Swedish Cancer Institute ( Site 0071), Seattle
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Nagre-recruitPhase 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Nagre-recruitPhase 1/2
- Research Site, Seattle
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Nagre-recruitPhase 3
- Fred Hutchinson Cancer Research Center, Seattle
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Nagre-recruitPhase 3
- Fred Hutchinson Cancer Research Center, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Nagre-recruitPhase 4
- Swedish Cancer Institute, Seattle
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Nagre-recruitPhase 4
- Swedish Cancer Institute, Seattle
Study of SGR-1505 in Mature B-Cell Neoplasms
Nagre-recruitPhase 1
- Fred Hutchinson Cancer Center, Seattle
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Nagre-recruitPhase 1
- Swedish Cancer Institute, Seattle
Pag-aaral para sa Chronic Lymphocytic Leukemia sa ibang lungsod
- Boston, MA31 pag-aaral
- Columbus, OH29 pag-aaral
- Durham, NC28 pag-aaral
- Washington, DC22 pag-aaral
- Rochester, MN20 pag-aaral
- New York City, NY20 pag-aaral
- Houston, TX18 pag-aaral
- Baldwin Park, CA18 pag-aaral
- Cincinnati, OH15 pag-aaral
- Milwaukee, WI15 pag-aaral
- Chicago, IL14 pag-aaral
- Nashville, TN13 pag-aaral
Iba pang pag-aaral sa Seattle
- Non-Small Cell Lung Cancer55 pag-aaral
- Kanser (lahat ng uri)48 pag-aaral
- Kanser sa Prostate45 pag-aaral
- Acute Myeloid Leukemia40 pag-aaral
- Metastatic Cancer39 pag-aaral
- Kanser sa Suso37 pag-aaral
- Colorectal Cancer35 pag-aaral
- Kanser sa Baga34 pag-aaral
- Kanser sa Ovary29 pag-aaral
- Kanser sa Pancreas22 pag-aaral
- Multiple Myeloma22 pag-aaral
- Acute Lymphoblastic Leukemia22 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.